Product Description

🔹 Product Overview
Eligard 22.5 mg Injection is a prescription hormone therapy medication used primarily in the treatment of advanced prostate cancer.
Contains Leuprolide Acetate 22.5 mg, a gonadotropin-releasing hormone (GnRH) agonist.
Helps reduce testosterone production, which can slow the growth of prostate cancer cells.

🔹 Key Uses
Treatment of advanced prostate cancer
Long-term androgen deprivation therapy (ADT)
Helps control symptoms associated with prostate cancer
Supports management of hormone-sensitive prostate tumors

🔹 Composition
Active ingredient: Leuprolide Acetate 22.5 mg
Belongs to the GnRH agonist class
Available as a depot injection for extended-release action

🔹 How It Works
Initially stimulates and then suppresses pituitary hormone release
Significantly lowers testosterone production in men
Reduces hormonal stimulation of prostate cancer cells
Helps slow disease progression

🔹 Key Benefits
Effective prostate cancer hormone therapy
Long-acting depot formulation for convenient dosing
Helps maintain low testosterone levels
Supports long-term cancer management
Reduces symptoms associated with advanced prostate cancer

🔹 Dosage and Administration
Administered by a healthcare professional
Given as a subcutaneous injection
Dosing schedule determined by the treating oncologist
Regular monitoring of PSA and testosterone levels may be required

🔹 Possible Side Effects
Hot flashes
Fatigue
Injection site reactions
Increased sweating
Joint or muscle pain
Reduced libido

🔹 Precautions
Use only under specialist medical supervision
Regular monitoring of hormone and PSA levels is recommended
Inform your doctor about heart disease, diabetes, or osteoporosis
May temporarily worsen symptoms during the initial phase of treatment
Follow scheduled follow-up appointments carefully